Dutch AI Startup Secures €2.3 Million to Predict Surgery Complications Before They Happen

2026-02-15 bio

Netherlands, Sunday, 15 February 2026.
Healthplus.ai’s revolutionary PERISCOPE system can save hospitals up to €4 million annually by predicting post-operative infection risks for individual patients and providing targeted preventive actions.

Healthcare Innovation Category and Market Impact

This funding announcement represents a significant development in the healthtech sector, specifically in the medical technology (MedTech) category focused on surgical risk prediction [1]. Healthplus.ai’s PERISCOPE® system addresses one of healthcare’s most pressing challenges: post-operative complications, which represent a substantial cost burden and source of increased workload pressure on medical staff [1]. The technology demonstrates how artificial intelligence can be applied to predict individual patient infection risks following surgical procedures, transforming reactive healthcare into a proactive, prevention-focused approach [1].

The Technology Behind PERISCOPE®

PERISCOPE® operates as an ISO- and CE-certified AI system that analyzes individual patient data to predict post-operative infection risks and provides targeted preventive actions for healthcare teams [1][4]. The system’s architecture allows for seamless integration with existing Electronic Patient Record (EPD) systems used across Dutch and broader European markets, including Epic, Oracle Cerner, and ChipSoft [1]. The technology features automatic calibration capabilities, ensuring accurate predictions across different hospital environments while maintaining compliance with all regulatory requirements [1]. This integration capability represents a crucial advantage in healthcare technology adoption, as it eliminates the need for hospitals to overhaul their existing digital infrastructure [1].

Financial Structure and Leadership

The €2.3 million late-seed funding round, which closed on or before February 1, 2026, was led by Elevating Capital and co-led by LUMO Labs, with participation from Pathena Venture Capital, Leistone (Renza Family), and ROM InWest [1][4]. Dr. Bart Geerts, CEO and founder of Healthplus.ai, emphasized the strategic focus on integrating clinically validated, regulatory-approved AI into daily hospital operations through close collaboration with surgical specialists, nursing staff, and IT teams [1]. The Amsterdam-based company plans to utilize this investment to accelerate European expansion while simultaneously preparing for entry into the United States market [1][4].

Economic Impact and Regional Significance

The financial implications of PERISCOPE® extend far beyond the initial investment, with hospitals potentially saving up to €4 million annually by reducing post-operative complications [1]. Sara Schaafsma, Investment Manager at ROM InWest, highlighted how accurate patient stratification enables healthcare providers to develop superior treatment plans, intervene more rapidly with high-risk patients, and safely discharge low-risk patients earlier [1]. This technology exemplifies the innovation capabilities of North Holland’s Life Sciences & Health ecosystem, which combines world-class AI expertise with clinical healthcare innovation [1]. The region’s strategic position as a European AI leader, supported by Amsterdam’s knowledge institutions, research centers, and medical facilities, creates an internationally competitive environment for health technology development [1]. ROM InWest’s investment strategy specifically targets companies that demonstrate the potential for international breakthrough success while strengthening the regional healthcare innovation ecosystem [1].

Bronnen

AI healthcare surgical prediction